Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 ... 7thSpace Interactive (press release) RA patients on rituximab had significantly lower (P <0.001) and SpA on anti-TNF monotherapy significantly better response rates compared to other treatment groups (P 0.001 to 0.033). Higher age (P <0.001) predicted impaired immune response. Antibody ... |
